STAT
MAY 15, 2024
WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.
PharmaVoice
MAY 15, 2024
After missing analysts’ earnings expectations for Mounjaro sales in the first quarter due to overwhelming demand, Lilly is also dealing with a legal loss and incoming pricing questions from lawmakers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 15, 2024
U.S. drug deaths decreased slightly in 2023, according to new data, the first decrease in five years. Last year saw 107,543 U.S. drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022.
The Pharmacist
MAY 15, 2024
The equivalent of 10 local pharmacies are closing their doors each week, according to analysis by the National Pharmacy Association (NPA). And the number of bricks and mortar pharmacies closing between January and April 2024 is nearly 50% higher than in the same period last year, the NPA said. The association’s analysis of NHS Business […] The post Ten pharmacies closing every week, NPA analysis suggests appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MAY 15, 2024
To better understand problems in the brain’s blood vessels that may lead to stroke, we need a better way to see them. Cardiovascular imaging can peer inside coronary arteries to spot clots blocking blood flow to the heart, but those tools are dangerously large for the smaller arteries inside the brain that twist and turn in tortuous ways. Now researchers have designed a probe minuscule enough to fit inside the microcatheters that surgeons snake into cerebral arteries to place reinforcing
Pharma Times
MAY 15, 2024
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
MAY 15, 2024
The autoimmune disease, which affects 1.
STAT
MAY 15, 2024
Physicians Frederick Banting and John MacLeod declined to be listed on the patent for insulin in 1923; their co-inventors Charles Best and James Collip sold the patent to the University of Toronto for $1. But despite the discoverers’ efforts to make insulin available and cheap for everyone, it has today become the poster child for soaring pharmaceutical prices.
BioPharma Dive
MAY 15, 2024
The annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of Leqembi for approval, looks “more realistic” than previous guidance, according to Jefferies analysts.
STAT
MAY 15, 2024
Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S. Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
MAY 15, 2024
GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.
STAT
MAY 15, 2024
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the sobering possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple bourbon.
pharmaphorum
MAY 15, 2024
Five home-testing devices to diagnose sleep apnoea, which can affect the health of around 2.5 million adults in the UK, have been recommended for NHS use by NICE.
STAT
MAY 15, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of my colleagues are traveling to San Francisco (without me) for our Breakthrough West Summit happening tomorrow. If you have FOMO like me, you can still register to get a virtual pass.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
MAY 15, 2024
MHRA's innovative regulatory approach enables Nuwiq's accelerated clinical trial timeline for haemophilia patients. Learn how their flexible approach is speeding access to new treatments.
STAT
MAY 15, 2024
WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States. Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee.
pharmaphorum
MAY 15, 2024
BMS gets another FDA approval for its CD19-directed CAR-T Breyanzi, this time as a third-line or later therapy for follicular lymphoma
STAT
MAY 15, 2024
An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease. The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
MAY 15, 2024
The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer
Express Pharma
MAY 15, 2024
Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic therapy.
pharmaphorum
MAY 15, 2024
House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs including WuXi AppTec, MGI and BGI
Express Pharma
MAY 15, 2024
To understand opportunities and challenges in the evolving Asia-Pacific healthcare landscape, Bain & Company conducted a survey in Q4 2023 to uncover consumer-centric trends in healthcare consumption. The survey was distributed to 2,300 consumers across nine Asia-Pacific geographies (Australia, China, Hong Kong, India, Indonesia, Malaysia, Philippines, Singapore, and Vietnam) in a process similar to the data collections we conducted previously in 2019 and 2021.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Commerce
MAY 15, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.
pharmaphorum
MAY 15, 2024
AbbVie joins a select group of big pharma groups working on psychedelic medicines, paying $65m on an option deal with Gilgamesh Pharma
Drug Patent Watch
MAY 15, 2024
Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier.
pharmaphorum
MAY 15, 2024
Eisai and Biogen have filed a rolling biologics license application in the US for a subcutaneous formulation of Alzheimer’s disease therapy Leqembi that was delayed by the FDA on procedural grounds.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmafile
MAY 15, 2024
Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This makes the solution one of the first available in the US, allowing more women to utilise an accessible screening option. The post FDA approves Roche’s HPV self-collection screening option appeared first on Pharmafile.
Pharmaceutical Technology
MAY 15, 2024
Verismo Therapeutics announced FDA clearance for a Phase I trial of its CAR-T therapy to treat non-Hodgkin lymphoma.
European Pharmaceutical Review
MAY 15, 2024
Research has demonstrated a cost-effective storage solution for compounded faricimab kept for a maximum of 28 days. Authors of the paper stated that it provides off-label use of the anti- vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2) biologic , “while maintaining safety in the treatment of patients”. Their study compared the stability, sterility, and binding affinity to VEGF and Ang-2 of faricimab.
Pharmaceutical Technology
MAY 15, 2024
The US agency rejected the expanded use of Dynavax’s vaccine for adults on haemodialysis, citing insufficient efficacy and safety data.
pharmaphorum
MAY 15, 2024
AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to respond to changes. The two companies will work together on the development of a “next-generation” of psychiatric medicines, although – for now – the drugs themselves and the target indications are being kept under wraps. other than to say they include mood and anxiety disorders.
Expert insights. Personalized for you.
364 
Let's personalize your content